Shire to Buy ViroPharma for Around $4.2 Billion

Shire to Buy ViroPharma for Around $4.2 Billion

In order to establish itself in providing treatments for rare disease, Shire Plc is going to buy ViroPharma Inc. The deal has taken place for around $4.2 billion and Shire will be paying $50 a share and that too in cash.

The recent deal is considered to be the third one for Shire. The purchase will allow Shire to have an access to Cinryze, a medicine meant for the treatment of hereditary angioedema, an inflammatory condition.

The company has said that the deal will help in raising Shire's earnings per share. In fact, as the announcement of the deal was made, Shire was able to witness a rise of 3.5% amounting to 2,894 pence.

"It's a deal that fits with our strategy of increased focus on high-growth speciality markets, particularly rare diseases", said Flemming Ornskov, CEO of Shire.

Ornskov talked about Cinryze and said that it will act a grown engine for the company. Moreover, it is an attractive drug that will prove beneficial for the company.

In addition, it has been revealed that Shire has announced that it has been planning to stop a number of programs that are taking place out of the field of rare disease.


FrenchTribune Specials

Scientists develop new way to create micro-robots that could deliver drugs and p

Scientists at Ecole Polytechnique Federale de Lausanne (EPFL) and ETH Zurich have come up with a new way to make microrobots that may potentially be used in the human body to deliver drugs and do medical operations.

Over the last some years, groups of scientists have been studying distinct ways of using miniature robots for medical...

Most Popular

Facebook Messenger app grows to more than 1 billion users

On Wednesday, social network Facebook announced that its...

Elon Musk unveils Tesla’s plans to offer wider range of vehicles, products and s

In a Wednesday blog post titled ‘Master Plan, Part Deux...

Gonorrhea may become untreatable, says CDC report

Gonorrhea is a sexually transmitted bacterial infection...

Researchers count Elephants to know their recent Population decline

African elephants are not having a good time as their...

Poll

Can Greece Come out of Economic Problems: